Evolent Health, Inc. (NYSE:EVH) Stake Decreased by Rock Point Advisors LLC

Rock Point Advisors LLC lessened its holdings in shares of Evolent Health, Inc. (NYSE:EVH) by 5.4% in the 3rd quarter, Holdings Channel reports. The fund owned 465,782 shares of the technology company’s stock after selling 26,605 shares during the quarter. Evolent Health accounts for 3.6% of Rock Point Advisors LLC’s holdings, making the stock its 6th largest holding. Rock Point Advisors LLC’s holdings in Evolent Health were worth $13,172,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. RA Capital Management L.P. increased its stake in shares of Evolent Health by 125.0% in the 1st quarter. RA Capital Management L.P. now owns 5,736,132 shares of the technology company’s stock worth $188,088,000 after acquiring an additional 3,187,000 shares during the last quarter. William Blair Investment Management LLC increased its position in Evolent Health by 35.2% during the second quarter. William Blair Investment Management LLC now owns 5,026,043 shares of the technology company’s stock worth $96,098,000 after purchasing an additional 1,308,376 shares during the last quarter. First Light Asset Management LLC boosted its holdings in Evolent Health by 401.5% in the 2nd quarter. First Light Asset Management LLC now owns 1,445,305 shares of the technology company’s stock valued at $27,634,000 after purchasing an additional 1,157,124 shares during the last quarter. Engaged Capital LLC boosted its holdings in Evolent Health by 26.1% in the 2nd quarter. Engaged Capital LLC now owns 4,111,458 shares of the technology company’s stock valued at $78,611,000 after purchasing an additional 850,000 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Evolent Health by 24.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,048,341 shares of the technology company’s stock valued at $39,164,000 after buying an additional 406,837 shares during the period.

Evolent Health Trading Down 0.2 %

Evolent Health stock traded down $0.02 during midday trading on Tuesday, reaching $12.19. The stock had a trading volume of 124,112 shares, compared to its average volume of 1,786,817. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.04 and a current ratio of 1.04. Evolent Health, Inc. has a twelve month low of $11.17 and a twelve month high of $35.00. The stock has a market capitalization of $1.42 billion, a PE ratio of -13.42 and a beta of 1.58. The stock’s 50-day simple moving average is $22.89 and its 200 day simple moving average is $23.64.

Analysts Set New Price Targets

EVH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. decreased their price objective on Evolent Health from $45.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday. Stephens cut Evolent Health from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $38.00 to $16.00 in a report on Friday, November 8th. JMP Securities cut their price objective on Evolent Health from $34.00 to $31.00 and set a “market outperform” rating for the company in a research report on Friday, August 9th. KeyCorp initiated coverage on shares of Evolent Health in a research report on Friday, October 11th. They issued an “overweight” rating and a $35.00 target price on the stock. Finally, Royal Bank of Canada restated an “outperform” rating and set a $20.00 price target on shares of Evolent Health in a research report on Tuesday, November 12th. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $25.90.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.